 |
市場調查報告書
商品編碼
1831955
2025 年至 2033 年組織庫市場報告（按產品、應用、組織類型和地區）Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2025-2033 |
||||||
2024年，全球組織庫市場規模達20億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到46億美元，2025-2033年期間的複合年成長率（CAGR）為9.6%。蓬勃發展的研發投入、冷凍保存技術的進步、慢性病和遺傳性疾病的增加、個人化醫療需求的不斷成長、基因組學的進步、監管的進步、戰略合作以及研究人員意識的增強，都是推動市場成長的一些因素。
組織庫市場趨勢：
增加研發投入
全球組織庫市場的成長主要得益於研發投入的不斷增加，尤其是在再生醫學和個人化治療領域。隨著科學界和醫學界對疾病理解和治療的不斷進步，組織樣本捐贈數量顯著成長，這進一步推動了市場的成長。這些樣本對於理解疾病的生物機制、測試新藥的潛在療效以及識別可能受益於特定藥物的患者群體至關重要。隨著幹細胞治療和基因編輯等領域研究的進展，人們對特定組織樣本的依賴日益加深，進一步增加了對保存完好、人人可用的組織庫的需求。例如，加州大學舊金山分校最近啟動了全球首個組織庫，其樣本來自新冠肺炎患者捐贈。先前有研究表明，新冠病毒可以在人體內持續存活，這可能是了解這種殘疾疾病病因並找到有效治療方法的關鍵。
低溫保存技術的進展
冷凍保存技術的發展是推動全球組織庫市場發展的主要因素之一。冷凍保存是一種將活組織和細胞在冰點以下儲存並保持其活力的有效方法。快速發展的技術加速了這一進程，大大提高了保存組織的品質和耐久性。此外，新的冷凍保護劑和冷卻技術也得到了發展，例如玻璃化冷凍技術可以防止冰晶形成，避免冰晶破壞細胞結構。此外，冷凍保存的自動化進一步提高了操作的自動化程度，有助於最大限度地減少人為錯誤並提高處理量，從而促進了市場的成長。
慢性病和遺傳性疾病的盛行率不斷上升
遺傳疾病和慢性病發病率的不斷上升是加速全球組織庫市場發展的主要因素之一。根據沙烏地阿拉伯全國人口調查，成年男性和女性的糖尿病 (DM) 盛行率估計為男性 14.8%，而女性盛行率較低，為 11.7%。癌症、心血管疾病和糖尿病等慢性疾病需要深入研究，以了解其病理生理機制並開發有效的治療方法。組織庫為此類研究提供了至關重要的資源，它提供了種類繁多的生物樣本，對於研究疾病機制、開發新藥和測試療效至關重要。
組織庫市場區隔：
按產品分類：
- 裝置
- 低溫保存設備
- 解凍設備
- 品質管制設備
- 其他
- 介質和耗材
設備佔大部分市場佔有率
設備細分市場的發展動力源自於市場對先進且可靠的組織保存和分析系統日益成長的需求。自動化和改進的冷凍保存技術等技術進步對於提高組織處理和儲存的效率和準確性至關重要。研究活動和臨床試驗的增多需要最先進的設備來確保高品質和可重複的結果。此外，個人化醫療和再生療法的日益成長的關注也推動了對能夠管理多樣化和複雜組織樣本的專用設備的需求。品質和安全標準的監管要求進一步推動了先進設備的採用。醫療基礎設施投資的增加以及全球組織庫的擴張也推動了對先進設備的需求。
按應用分類：
- 療法
- 醫學研究
- 其他
治療學佔行業最大佔有率
個人化醫療需求的日益成長推動了治療領域的發展，個人化醫療需要使用特定的高品質組織樣本來根據個別基因圖譜制定個人化治療方案。基因組學和生物技術的進步進一步推動了這一成長，因為它們使研究人員和臨床醫生能夠更好地理解複雜的疾病機制並開發標靶療法。此外，慢性病和遺傳性疾病的盛行率不斷上升，加速了對創新治療方案的需求，導致研發活動激增。藥物研發領域的技術進步，包括高通量篩選和複雜的生物資訊工具，也至關重要，因為它們依賴多樣化且特徵明確的生物樣本來識別和驗證新的治療標靶。再生醫學和細胞療法（例如幹細胞治療和組織工程）的日益重視，推動了對強大的組織庫基礎設施的需求，這些基礎設施為這些尖端療法提供了必要的材料。
依組織類型分類：
- 心血管組織
- 肺組織
- 腎臟組織
- 胰臟組織
- 肝組織
- 眼紙
- 其他
心血管組織代表著領先的細分市場
心血管疾病 (CVD) 的發生率不斷上升，是全球主要死亡原因之一，心血管組織細分市場因此蓬勃發展。 CVD 病例的激增需要大量的研發投入，從而推動了對高品質心血管組織的需求，用於研究疾病機制、開發創新療法和測試治療干預措施。組織工程和再生醫學的進步也至關重要，因為它們使得創建和使用心血管組織能夠開發個人化療法並改善患者預後。對個人化醫療的日益重視進一步推動了需求，因為臨床醫生需要尋找與患者個體特徵相符的組織樣本，以便制定更有效的治療方案。此外，生物樣本庫技術的不斷進步，包括改進的保存方法和更優的組織表徵技術，提高了心血管組織的品質和可用性。
按地區分類：
- 北美洲
- 美國
- 加拿大
- 亞太
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 其他
- 歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 俄羅斯
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東和非洲
北美引領市場，佔據最大的組織庫市場佔有率
該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是組織庫最大的區域市場。
北美地區市場受醫療保健研究和生物技術投資不斷成長的驅動，這顯著增強了對高品質組織樣本的需求。該地區擁有先進的研究機構和蓬勃發展的製藥業，這加速了對維護良好的組織樣本庫的需求，以支持再生醫學、個人化治療和藥物開發領域的創新研究。此外，北美慢性病和遺傳性疾病的發生率不斷上升，推動了對多樣化組織樣本的需求，以了解疾病機制並開發有效的治療方法。冷凍保存和組織儲存技術的進步進一步促進了市場發展，提供了延長保存組織活力並提高整體研究品質的解決方案。北美的監管環境也發揮著至關重要的作用；嚴格的標準和準則確保了組織樣本庫實踐的品質和安全，從而增強了人們對組織樣本庫的信任和可靠性。
本報告回答的關鍵問題
- 2024 年全球組織庫市場規模是多少
- 2025-2033年全球組織庫市場的預期成長率是多少
- 推動全球組織庫市場的關鍵因素有哪些
- COVID-19 對全球組織庫市場有何影響
- 根據產品類型，全球組織庫市場如何分類？
- 根據應用情況，全球組織庫市場如何分類
- 根據組織類型，全球組織庫市場如何分類
- 全球組織庫市場的主要區域有哪些
- 全球組織庫市場的主要參與者/公司有哪些
本報告回答的關鍵問題
- 2024年全球組織庫市場規模？ 2025-2033年全球組織庫市場的預期成長率是多少？
- 推動全球組織庫市場發展的關鍵因素有哪些？
- COVID-19 對全球組織庫市場有何影響？
- 根據產品，全球組織庫市場是如何分佈的？
- 根據應用，全球組織庫市場是如何分佈的？
- 根據組織類型，全球組織庫市場是如何分類的？
- 全球組織庫市場的主要區域有哪些？
- 全球組織庫市場的主要參與者/公司有哪些？
目錄
第1章：前言
第2章：範圍與方法
- 研究目標
- 利害關係人
- 資料來源
- 主要來源
- 二手資料
- 市場評估
- 自下而上的方法
- 自上而下的方法
- 預測方法
第3章：執行摘要
第4章：簡介
第5章：全球組織庫市場
- 市場概況
- 市場表現
- COVID-19的影響
- 市場預測
第6章：市場區隔：依產品
- 裝置
- 關鍵部分
- 低溫保存設備
- 解凍設備
- 品質管制設備
- 其他
- 關鍵部分
- 介質和耗材
第7章：市場區隔：依應用
- 療法
- 醫學研究
- 其他
第8章：市場區隔：依衛生紙類型
- 心血管組織
- 肺組織
- 腎臟組織
- 胰臟組織
- 肝組織
- 眼紙
- 其他
第9章：市場細分：依地區
- 北美洲
- 美國
- 加拿大
- 亞太
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 其他
- 歐洲
- 德國
- 法國
- 英國
- 義大利
- 西班牙
- 俄羅斯
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東和非洲
第 10 章：SWOT 分析
第 11 章：價值鏈分析
第 12 章：波特五力分析
第13章：價格分析
第 14 章：競爭格局
- 市場結構
- 關鍵參與者
- 關鍵參與者簡介
- AMS Biotechnology
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- Brooks Life Sciences Inc. (Brooks Automation Inc.)
- Eppendorf AG
- Merck KGaA
- PHC Corporation
- QIAGEN NV
- Sartorius AG
- Taylor-Wharton
- Thermo Fisher Scientific Inc.
- VWR International LLC (Avantor Inc)
The global tissue banking market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033. The burgeoning research and development (R&D) investments, advancements in cryopreservation, the rise in chronic diseases and genetic disorders, growing demand for personalized medicine, improvements in genomics, regulatory advancements, strategic collaborations, and enhanced awareness among researchers are some of the factors boosting the market growth.
Tissue Banking Market Trends:
Increasing Investments in Research and Development
The global tissue banking market is predominantly driven in growth by the increasing investment in R&D, especially for regenerative medicine and personalized therapies. With the advancements in disease understanding and treatment by scientific and medical communities, there is a significant growth in tissue sample donations, which is further fueling the market growth. These samples are key to understanding the biology of disease, testing new drugs for potential use in patients, and identifying patient populations that may benefit from a particular drug. As research progresses in fields such as stem cell therapy and gene editing, it thrusts the reliance on specific tissue samples, further increasing the demand for well-preserved banks of tissues accessible by everyone. For instance, recently, UC San Francisco launched the world's first tissue bank with samples donated by patients with long COVID. The move follows research indicating that the virus can continue to linger throughout the body and may hold the key to understanding the cause of the debilitating disorder and lead to effective treatments.
Advances in Cryopreservation Technologies
The development of cryopreservation technologies is one of the major factors which is pushing the global tissue banking market. Cryopreservation is an effective way to store living tissue and cells below freezing temperatures while keeping it viable. Rapidly advancing technologies have accelerated this process, making the quality of preserved tissues and their durability much better. Additionally, new cryoprotectants and cooling techniques are developed, such as vitrification that prevents ice crystal formation, which can otherwise damage cell structures. Moreover, automation in cryopreservation further automates the operations and helps in minimizing human error and increasing throughput, which is bolstering the market growth.
Growing Prevalence of Chronic Diseases and Genetic Disorders
The growing incidence of genetic diseases and chronic conditions is one of the primary factor accelerating the global tissue banking market. As per the national survey carried out in Saudi population, Diabetes Mellitus (DM) among adult males and females were estimated with prevalence rates 14.8% for male, while it was lower for female group where 11.7%. Chronic conditions such as cancer, cardiovascular diseases, and diabetes require extensive research to understand their pathophysiology and develop effective treatments. Tissue banks provide critical resources for this research by offering a diverse array of biological samples, which are essential for studying disease mechanisms, developing new drugs, and testing treatment efficacy.
Tissue Banking Market Segmentation:
Breakup by Product:
- Equipment
- Cryopreservation Equipment
- Thawing Equipment
- Quality Control Equipment
- Others
- Media and Consumables
Equipment accounts for the majority of the market share
The equipment segment is driven by the increasing demand for advanced and reliable systems for tissue preservation and analysis. Technological advancements, such as automation and improved cryopreservation techniques, are crucial in enhancing the efficiency and accuracy of tissue handling and storage. The rise in research activities and clinical trials necessitates state-of-the-art equipment to ensure high-quality and reproducible results. Additionally, the growing focus on personalized medicine and regenerative therapies fuels the need for specialized equipment capable of managing diverse and complex tissue samples. Regulatory requirements for quality and safety standards further drive the adoption of sophisticated equipment. Increased investments in healthcare infrastructure and the expansion of tissue banks globally also contribute to the demand for advanced equipment.
Breakup by Application:
- Therapeutics
- Medical Research
- Others
Therapeutics holds the largest share of the industry
The therapeutics segment is driven by the increasing demand for personalized medicine, which necessitates the use of specific, high-quality tissue samples to tailor treatments to individual genetic profiles. Advances in genomics and biotechnology further fuel this growth, as they enable researchers and clinicians to better understand complex disease mechanisms and develop targeted therapies. Additionally, the rising prevalence of chronic diseases and genetic disorders accelerates the need for innovative therapeutic solutions, leading to a surge in research and development activities. Technological advancements in drug discovery, including high-throughput screening and sophisticated bioinformatics tools, are also pivotal, as they rely on diverse and well-characterized biological samples to identify and validate new therapeutic targets. The growing emphasis on regenerative medicine and cell therapies, such as stem cell treatments and tissue engineering, drives demand for robust tissue banking infrastructure, which provides essential materials for these cutting-edge therapies.
Breakup by Tissue Type:
- Cardiovascular Tissue
- Lung Tissue
- Kidney Tissue
- Pancreas Tissue
- Liver Tissue
- Eye Tissue
- Others
Cardiovascular Tissue represents the leading market segment
The cardiovascular tissue segment is driven by the increasing prevalence of cardiovascular diseases (CVDs), which are among the leading causes of mortality globally. This surge in CVD cases necessitates extensive research and development efforts, fueling the demand for high-quality cardiovascular tissues for studying disease mechanisms, developing innovative treatments, and testing therapeutic interventions. Advances in tissue engineering and regenerative medicine are also pivotal, as they enable the creation and use of cardiovascular tissues for developing personalized therapies and improving patient outcomes. The growing emphasis on personalized medicine further drives demand, as clinicians seek tissue samples that match individual patient profiles for more effective treatment plans. Additionally, ongoing advancements in biobanking technologies, including improved preservation methods and better tissue characterization techniques, enhance the quality and availability of cardiovascular tissues.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
North America leads the market, accounting for the largest tissue banking market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for tissue banking.
The North America regional market is driven by the increasing investments in healthcare research and biotechnology, which significantly bolster the demand for high-quality tissue samples. The presence of advanced research institutions and a robust pharmaceutical industry in the region accelerates the need for well-maintained tissue banks to support innovative studies in regenerative medicine, personalized therapies, and drug development. Additionally, the growing prevalence of chronic diseases and genetic disorders in North America drives the need for diverse tissue samples to understand disease mechanisms and develop effective treatments. Technological advancements in cryopreservation and tissue storage further enhance the market, providing solutions that extend the viability of preserved tissues and improve overall research quality. The regulatory landscape in North America also plays a crucial role; stringent standards and guidelines ensure the quality and safety of tissue banking practices, which in turn fosters trust and reliability in tissue banks.
Competitive Landscape:
- The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), etc.
- Key players in the tissue banking market are actively engaged in a variety of strategic initiatives to enhance their market position and drive innovation. Leading companies are investing heavily in R&D to advance cryopreservation technologies, improve tissue storage methods, and develop new applications for tissue samples. This includes implementing cutting-edge automation and digital solutions to streamline operations, increase efficiency, and ensure high-quality preservation of biological materials. Additionally, these players are expanding their global footprint by establishing new tissue banks and forming strategic partnerships with academic institutions, biopharmaceutical companies, and healthcare organizations. To address the growing demand for specialized and well-characterized tissue specimens, key players are also focusing on diversifying their tissue collections and incorporating advanced genomic and molecular characterization techniques. Moreover, regulatory compliance and the establishment of rigorous quality control standards are priorities, ensuring that their practices meet international guidelines and enhance the reliability of tissue resources.
Key Questions Answered in This Report
- 1.What was the size of the global tissue banking market in 2024?
- 2.What is the expected growth rate of the global tissue banking market during 2025-2033?
- 3.What are the key factors driving the global tissue banking market?
- 4.What has been the impact of COVID-19 on the global tissue banking market?
- 5.What is the breakup of the global tissue banking market based on the product?
- 6.What is the breakup of the global tissue banking market based on the application?
- 7.What is the breakup of the global tissue banking market based on the tissue type?
- 8.What are the key regions in the global tissue banking market?
- 9.Who are the key players/companies in the global tissue banking market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Tissue Banking Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Equipment
- 6.1.1 Market Trends
- 6.1.2 Key Segments
- 6.1.2.1 Cryopreservation Equipment
- 6.1.2.2 Thawing Equipment
- 6.1.2.3 Quality Control Equipment
- 6.1.2.4 Others
- 6.1.3 Market Forecast
- 6.2 Media and Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Therapeutics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Medical Research
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
8 Market Breakup by Tissue Type
- 8.1 Cardiovascular Tissue
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Lung Tissue
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Kidney Tissue
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Pancreas Tissue
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Liver Tissue
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Eye Tissue
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 AMS Biotechnology
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 SWOT Analysis
- 14.3.3 Bio-Rad Laboratories Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Brooks Life Sciences Inc. (Brooks Automation Inc.)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Eppendorf AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 SWOT Analysis
- 14.3.6 Merck KGaA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 PHC Corporation
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 QIAGEN N.V.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Sartorius AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Taylor-Wharton
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.11 Thermo Fisher Scientific Inc.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 VWR International LLC (Avantor Inc)
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.1 AMS Biotechnology
List of Figures
- Figure 1: Global: Tissue Banking Market: Major Drivers and Challenges
- Figure 2: Global: Tissue Banking Market: Sales Value (in Billion USD), 2019-2024
- Figure 3: Global: Tissue Banking Market Forecast: Sales Value (in Billion USD), 2025-2033
- Figure 4: Global: Tissue Banking Market: Breakup by Product (in %), 2024
- Figure 5: Global: Tissue Banking Market: Breakup by Application (in %), 2024
- Figure 6: Global: Tissue Banking Market: Breakup by Tissue Type (in %), 2024
- Figure 7: Global: Tissue Banking Market: Breakup by Region (in %), 2024
- Figure 8: Global: Tissue Banking (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 9: Global: Tissue Banking (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 10: Global: Tissue Banking (Media and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 11: Global: Tissue Banking (Media and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 12: Global: Tissue Banking (Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 13: Global: Tissue Banking (Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 14: Global: Tissue Banking (Medical Research) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 15: Global: Tissue Banking (Medical Research) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 16: Global: Tissue Banking (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 17: Global: Tissue Banking (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 18: Global: Tissue Banking (Cardiovascular Tissue) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 19: Global: Tissue Banking (Cardiovascular Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 20: Global: Tissue Banking (Lung Tissue) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 21: Global: Tissue Banking (Lung Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 22: Global: Tissue Banking (Kidney Tissue) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 23: Global: Tissue Banking (Kidney Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 24: Global: Tissue Banking (Pancreas Tissue) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 25: Global: Tissue Banking (Pancreas Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 26: Global: Tissue Banking (Liver Tissue) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 27: Global: Tissue Banking (Liver Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 28: Global: Tissue Banking (Eye Tissue) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 29: Global: Tissue Banking (Eye Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 30: Global: Tissue Banking (Other Tissue Types) Market: Sales Value (in Million USD), 2019 & 2024
- Figure 31: Global: Tissue Banking (Other Tissue Types) Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 32: North America: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 33: North America: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 34: United States: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 35: United States: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 36: Canada: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 37: Canada: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 38: Asia-Pacific: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 39: Asia-Pacific: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 40: China: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 41: China: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 42: Japan: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 43: Japan: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 44: India: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 45: India: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 46: South Korea: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 47: South Korea: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 48: Australia: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 49: Australia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 50: Indonesia: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 51: Indonesia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 52: Others: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 53: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 54: Europe: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 55: Europe: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 56: Germany: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 57: Germany: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 58: France: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 59: France: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 60: United Kingdom: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 61: United Kingdom: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 62: Italy: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 63: Italy: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 64: Spain: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 65: Spain: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 66: Russia: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 67: Russia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 68: Others: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 69: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 70: Latin America: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 71: Latin America: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 72: Brazil: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 73: Brazil: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 74: Mexico: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 75: Mexico: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 76: Others: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 77: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 78: Middle East and Africa: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
- Figure 79: Middle East and Africa: Tissue Banking Market: Breakup by Country (in %), 2024
- Figure 80: Middle East and Africa: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
- Figure 81: Global: Tissue Banking Industry: SWOT Analysis
- Figure 82: Global: Tissue Banking Industry: Value Chain Analysis
- Figure 83: Global: Tissue Banking Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Tissue Banking Market: Key Industry Highlights, 2024 and 2033
- Table 2: Global: Tissue Banking Market Forecast: Breakup by Product (in Million USD), 2025-2033
- Table 3: Global: Tissue Banking Market Forecast: Breakup by Application (in Million USD), 2025-2033
- Table 4: Global: Tissue Banking Market Forecast: Breakup by Tissue Type (in Million USD), 2025-2033
- Table 5: Global: Tissue Banking Market Forecast: Breakup by Region (in Million USD), 2025-2033
- Table 6: Global: Tissue Banking Market: Competitive Structure
- Table 7: Global: Tissue Banking Market: Key Players
